Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.67 |
| ▸ | CA1 | P00915 | 5/20 | 0.67 |
| ▸ | CA2 | P00918 | 5/20 | 0.67 |
| ▸ | CA7 | P43166 | 5/20 | 0.67 |
| ▸ | CA9 | Q16790 | 5/20 | 0.67 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.64 |
| ▸ | GAA | P10253 | 6/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.64 |
| ▸ | MAPT | P10636 | 3/20 | 0.64 |
| ▸ | HPGD | P15428 | 3/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.61 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.61 |
| ▸ | CFTR | P13569 | 3/20 | 0.58 |
| ▸ | GLA | P06280 | 2/20 | 0.53 |
| ▸ | CASP1 | P29466 | 1/20 | 0.53 |
| ▸ | CASP7 | P55210 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4826905 | 0.85 | ALDH1A1 (0.68) | CA12CA1CA2CA7CA9 | |
| SCHEMBL267307 | 0.83 | KDM4E (0.62) | CA1CA2ALDH1A1KDM4EGAA | |
| SCHEMBL7529190 | 0.82 | KDM4E (0.66) | CA12CA1CA2CA7CA9 | |
| SCHEMBL6168887 | 0.82 | GAA (0.66) | CA12CA1CA2CA7CA9 | |
| SCHEMBL19169070 | 0.82 | KDM4E (0.49) | CA12CA1CA2CA7CA9 | |
| SCHEMBL158999 | 0.82 | CA12 (0.74) | CA12CA1CA2CA7CA9 | |
| Hydrochloric Acid SCHEMBL5100210 | 0.81 | ALDH1A1 (0.60) | CA1CA2ALDH1A1KDM4EGAA | |
| SCHEMBL2746519 | 0.81 | CA12 (0.57) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1129416 | 0.81 | ALDH1A1 (0.64) | ALDH1A1KDM4EGAAHSD17B10MAPT | |
| SCHEMBL2912873 | 0.81 | KDM4E (0.73) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250154095-A1 | SYNTHESIS METHOD OF AVENANTHRAMIDE C | DONG-A UNIVERSITY RESEARCH FOUNDATION FOR INDUSTRY-ACADEMY COOPERATION (KR) | 2025-05-15 | — | — | US | claimed |
| CN-116730657-B | Cold patch asphalt mixture and preparation method thereof | 芜湖城瑞路桥建设有限公司 | 2024-07-12 | — | — | CN | claimed |
| CN-117925335-A | Semiconductor titanium nitride cleaning solution, and preparation method and application thereof | 浙江奥首材料科技有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-116730657-A | Cold patch asphalt mixture and preparation method thereof | 芜湖城瑞路桥建设有限公司 | 2023-09-12 | — | — | CN | claimed |
| WO-2023140435-A1 | METHOD FOR SYNTHESIZING AVENANTHRAMIDES C | 동아대학교 산학협력단 | 2023-07-27 | — | — | WO | claimed |
| CN-116377715-A | High-elasticity ultraviolet-resistant fabric and preparation method thereof | 盐城市金达纺织有限公司 | 2023-07-04 | — | — | CN | claimed |
| US-12594277-B2 | Macrocyclic ULK1/2 inhibitors | SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2026-04-07 | — | — | US | disclosed |
| US-20260022099-A1 | ARYL HYDROCARBON RECEPTOR AGONISTS AND USES THEREOF | NEXYS THERAPEUTICS, INC. (US) | 2026-01-22 | — | — | US | disclosed |
| US-20250326713-A1 | INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | MERCK SHARP & DOHME LLC (US) | 2025-10-23 | — | — | US | disclosed |
| US-20250312362-A1 | INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | MERCK SHARP & DOHME LLC (US) | 2025-10-09 | — | — | US | disclosed |
| US-12371408-B2 | Aryl hydrocarbon receptor agonists and uses thereof | NEXYS THERAPEUTICS, INC. (US) | 2025-07-29 | — | — | US | disclosed |
| EP-4584258-A1 | RAPIDLY ACCELERATED FIBROSARCOMA (RAF) DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE | Arvinas Operations, Inc. (US) | 2025-07-16 | — | — | EP | disclosed |
| CN-120137338-A | Anti-aging polypropylene material and preparation method thereof | 南通金威复合材料有限公司 | 2025-06-13 | — | — | CN | disclosed |
| EP-0638075-B1 | THIAZOLE OR IMIDAZOLE DERIVATIVES AS MAILLARD REACTION INHIBITORS | OTSUKA PHARMA CO LTD (JP) | 2002-01-16 | — | — | EP | disclosed |
| WO-2001009093-A1 | BENZENAMINE DERIVATIVES AS ANTI-COAGULANTS | BERLEX LABORATORIES, INC. (US) | 2001-02-08 | — | — | WO | disclosed |
| EP-0855387-A1 | 2-ACYLAMINOBENZAMIDE DERIVATIVES AND PREVENTIVE AND REMEDY FOR DISEASES CAUSED BY THE SUPERMULTIPLICATION OF VASCULAR INTIMAL CELLS | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 1998-07-29 | — | — | EP | disclosed |
| US-5677322-A | THERAPY FOR AGING, DIABETES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1997-10-14 | — | — | US | disclosed |
| US-5532138-A | Method and kits for determining peroxidatively active catalysts | BEHRINGWERKE AG (DE) | 1996-07-02 | — | — | US | disclosed |
| EP-0638075-A1 | THIAZOLE OR IMIDAZOLE DERIVATIVES AS MAILLARD REACTION INHIBITORS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1995-02-15 | — | — | EP | disclosed |
| WO-1994019335-A1 | THIAZOLE OR IMIDAZOLE DERIVATIVES AS MAILLARD REACTION INHIBITORS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1994-09-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12594277-B2 | Macrocyclic ULK1/2 inhibitors | ULK1, ULK2, ULK3 | CA12 4504/4885CA1 4726/4885CA2 3061/4885 |
| US-20250154095-A1 | SYNTHESIS METHOD OF AVENANTHRAMIDE C | OAT, MCCC2, OTC | CA12 408/4885CA1 602/4885CA2 500/4885 |
| US-20250312362-A1 | INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | MSRB3, ABCC1, MRPS34 | CA12 4275/4885CA1 4753/4885CA2 2766/4885 |
| US-12371408-B2 | Aryl hydrocarbon receptor agonists and uses thereof | AHR, ARNT, NR1H2 | CA12 4778/4885CA1 4417/4885CA2 4744/4885 |
| US-20260022099-A1 | ARYL HYDROCARBON RECEPTOR AGONISTS AND USES THEREOF | AHR, NR1H4, CNR1 | CA12 4257/4885CA1 2945/4885CA2 3205/4885 |
| US-20250326713-A1 | INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | MSRB3, ARSA, ABCG2 | CA12 4654/4885CA1 4834/4885CA2 2632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.